Financial information, reports, calendar and more
Interim Report Q3 – Nov. 15, 2019
Affibodys latest Press releases
Affibody in short
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Upcoming reports Financial calendar
- Interim Report Q3 (Nov. 15, 2019)